Cat and mouse: the analytical toxicology of designer drugs.
暂无分享,去创建一个
[1] A. Winstock,et al. Mephedrone: still available and twice the price , 2010, The Lancet.
[2] E. Vuori,et al. Application of accurate mass measurement to urine drug screening. , 2005, Journal of analytical toxicology.
[3] Christopher Smith,et al. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP. , 2008, Journal of analytical toxicology.
[4] Wolfgang Weinmann,et al. Bioanalysis of new designer drugs. , 2010, Bioanalysis.
[5] H. Maurer. Chemistry, Pharmacology, and Metabolism of Emerging Drugs of Abuse , 2010, Therapeutic drug monitoring.
[6] Simon D Brandt,et al. Analyses of second-generation 'legal highs' in the UK: initial findings. , 2010, Drug testing and analysis.
[7] F. Peters,et al. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. , 2003, Journal of mass spectrometry : JMS.
[8] Lawrence D Phillips,et al. Drug harms in the UK: a multicriteria decision analysis , 2010, The Lancet.